RDDT Q1 2026 Earnings EPS Blowout Surprises Wall Street Yet Shares Slide VRME Q4 2025 Earnings EPS Misses Estimates Amidst Challenging Quarter Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats AOMR Q1 2026 Earnings EPS Miss Amid Challenging Mortgage Environment OVLY Q3 2023 Earnings EPS of 089 Reflects Steady Performance Amid Challenging Rate Environment Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs